Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Koopman

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort studyAlice M Couwenberg, Johannes P M Burbach, Martijn P W Intven, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 29, 2020
The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancerJeroen W G Derksen, Sophie A Kurk, Petra H M Peeters, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 17, 2019
Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patientsSophie Kurk, Petra Peeters, Rebecca Stellato, et al.
Oncotarget|March 15, 2018
Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysisChristine Koch, Anna M Schwing, Eva Herrmann, et al.
Therapeutic Advances in Medical Oncology|August 23, 2024
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancerAstrid Kramer, Marjolein J E Greuter, Suzanna J Schraa, et al.
The British Journal of Surgery|January 19, 2023
Predicting early extrahepatic recurrence after local treatment of colorectal liver metastasesG E Wensink, Karen Bolhuis, Marloes A G Elferink, et al.
PEC Innovation|July 8, 2024
Improving sustainability of a patient decision aid for systemic treatment of metastatic colorectal cancer: A qualitative studySietske C M W van Nassau, Helene R Voogdt-Pruis, Vincent M W de Jong, et al.
JCO Clinical Cancer Informatics|July 17, 2024
Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal CancerMarinde J G Bond, Maarten van Smeden, Koen Degeling, et al.
Cancer Medicine|June 16, 2023
Prognostic value of Lynch syndrome, BRAF<sup>V600E</sup> , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohortsKoen Zwart, Frederieke H van der Baan, Romain Cohen, et al.
Patient Education and Counseling|March 11, 2019
Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancerLotte Keikes, Judith de Vos-Geelen, Jan Willem B de Groot, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort studyAlice M Couwenberg, Johannes P M Burbach, Martijn P W Intven, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 29, 2020
The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancerJeroen W G Derksen, Sophie A Kurk, Petra H M Peeters, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 17, 2019
Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patientsSophie Kurk, Petra Peeters, Rebecca Stellato, et al.
Oncotarget|March 15, 2018
Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysisChristine Koch, Anna M Schwing, Eva Herrmann, et al.
Therapeutic Advances in Medical Oncology|August 23, 2024
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancerAstrid Kramer, Marjolein J E Greuter, Suzanna J Schraa, et al.
The British Journal of Surgery|January 19, 2023
Predicting early extrahepatic recurrence after local treatment of colorectal liver metastasesG E Wensink, Karen Bolhuis, Marloes A G Elferink, et al.
PEC Innovation|July 8, 2024
Improving sustainability of a patient decision aid for systemic treatment of metastatic colorectal cancer: A qualitative studySietske C M W van Nassau, Helene R Voogdt-Pruis, Vincent M W de Jong, et al.
JCO Clinical Cancer Informatics|July 17, 2024
Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal CancerMarinde J G Bond, Maarten van Smeden, Koen Degeling, et al.
Cancer Medicine|June 16, 2023
Prognostic value of Lynch syndrome, BRAF<sup>V600E</sup> , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohortsKoen Zwart, Frederieke H van der Baan, Romain Cohen, et al.
Patient Education and Counseling|March 11, 2019
Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancerLotte Keikes, Judith de Vos-Geelen, Jan Willem B de Groot, et al.
Pageof 20